WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004035756) MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS KiF1 KINESIN PROTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/035756    International Application No.:    PCT/US2003/033100
Publication Date: 29.04.2004 International Filing Date: 16.10.2003
IPC:
C12N 9/14 (2006.01)
Applicants: CYTOKINETICS, INC. [US/US]; 280 East Grand Avenue, South San Francisco, CA 94080 (US) (For All Designated States Except US).
MAXON, Mary [US/US]; (US) (For US Only).
CHUA, Penelope [US/US]; (US) (For US Only)
Inventors: MAXON, Mary; (US).
CHUA, Penelope; (US)
Agent: STEVENS, Lauren L.,; Finnegan, Henderson, Farabow, Garrett & Dunner, L., L.P., 1300 I Street, N.W., Washington, D.C. 20005-3315 (US)
Priority Data:
60/419,780 17.10.2002 US
Title (EN) MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS KiF1 KINESIN PROTEIN
(FR) SEQUENCE DE NUCLEOTIDE MODIFIE CODANT UNE PROTEINE KINESINE KIF1 C ALBICANS
Abstract: front page image
(EN)The present invention relates to an isolated nucleic acid encoding a CaKif1 kinesin protein wherein the sequence of the isolated nucleic acid has been corrected for optimal expression in an Escherichia species or other organism. Disclosed are the nucleic acids, expression vectors, transformants obtained by the transformation with the expression vectors, methods of producing the modified protein using the transformant, and methods of screening for protein modulators.
(FR)L'invention concerne un acide nucléique isolé codant une protéine kinésine CaKif1 dont la séquence d'acide nucléique isolée a été corrigée en vue d'une expression optimale dans une espèce Escherichia ou d'autres organismes. L'invention concerne également des acides nucléiques, des vecteurs d'expression, des transformants obtenus par transformation des vecteurs d'expression, des procédés de production de la protéine modifiée au moyen du transformant, et des procédés de criblage destinés à des modulateurs protéiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)